{"id":"NCT00806026","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","briefTitle":"Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients","officialTitle":"Randomized, Double Blind, 12-Month Study Of Pregabalin In Subjects With Restless Legs Syndrome","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-12","primaryCompletion":"2011-05","completion":"2011-05","firstPosted":"2008-12-10","resultsPosted":"2012-09-27","lastUpdate":"2021-01-26"},"enrollment":731,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Idiopathic Restless Legs Syndrome"],"interventions":[{"type":"DRUG","name":"placebo and pregabalin","otherNames":["Lyrica"]},{"type":"DRUG","name":"pramipexol","otherNames":["Mirapex"]},{"type":"DRUG","name":"pramipexol","otherNames":["Mirapex"]},{"type":"DRUG","name":"Pregabalin","otherNames":["Lyrica"]},{"type":"DRUG","name":"pramipexol","otherNames":["Mirapex"]},{"type":"DRUG","name":"pramipexol","otherNames":["Mirapex"]}],"arms":[{"label":"PBO/PGB 300 mg","type":"EXPERIMENTAL"},{"label":"PBO/PPX 0.25 mg","type":"ACTIVE_COMPARATOR"},{"label":"PBO/PPX 0.5 mg","type":"ACTIVE_COMPARATOR"},{"label":"PGB 300 mg","type":"EXPERIMENTAL"},{"label":"PPX 0.25 mg","type":"ACTIVE_COMPARATOR"},{"label":"PPX 0.5 mg","type":"ACTIVE_COMPARATOR"}],"summary":"This purpose of this study is to investigate the efficacy and tolerability of pregabalin in treating idiopathic RLS patients for up to 12 months.","primaryOutcome":{"measure":"Restless Legs Syndrome (RLS) Symptom Severity","timeFrame":"Baseline","effectByArm":[{"arm":"Pregabalin 300 mg","deltaMin":22.3,"sd":5.73},{"arm":"Pramipexole 0.25 mg","deltaMin":22.4,"sd":5.37},{"arm":"Pramipexole 0.5 mg","deltaMin":22.1,"sd":5.19},{"arm":"Placebo","deltaMin":22.4,"sd":5.58}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":3},"locations":{"siteCount":110,"countries":["United States","Austria","Finland","Germany","Italy","Netherlands","Spain","Sweden","United Kingdom"]},"refs":{"pmids":["24521108"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A0081186&StudyName=Long%20Term%20Study%20Of%20Pregabalin%20In%20Idiopathic%20Restless%20Legs%20Syndrome%20Patients"]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":182},"commonTop":["Headache","Dizziness","Fatigue","Somnolence","Nasopharyngitis"]}}